NO992464L - FremgangsmÕte for fremstilling av rekombinante viruser - Google Patents

FremgangsmÕte for fremstilling av rekombinante viruser

Info

Publication number: NO992464L
Authority: NO; Norway
Prior art keywords: producing recombinant; recombinant viruses; producing; concerns; virus
Prior art date: 1996-11-22

Application number

NO992464A

Other languages

English (en)

Other versions

NO323937B1 (no

NO992464D0 (no

Inventor

Hul Ne Leblois-Prehaud

Michel Perricaudet

Emmanuelle Vigne

Patrice Yeh

Original Assignee

Rhone Poulenc Rorer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-22

Filing date

1999-05-21

Publication date

1999-06-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9497899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO992464(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-05-21 Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa

1999-05-21 Publication of NO992464D0 publication Critical patent/NO992464D0/no

1999-06-23 Publication of NO992464L publication Critical patent/NO992464L/no

2007-07-23 Publication of NO323937B1 publication Critical patent/NO323937B1/no

Links

241000700605 Viruses Species 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 3
230000000295 complement effect Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
241000701447 unidentified baculovirus Species 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14041—Use of virus, viral particle or viral elements as a vector
- C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Organic Chemistry (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Virology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pens And Brushes (AREA)
Materials For Medical Uses (AREA)

NO19992464A 1996-11-22 1999-05-21 Rekombinante hjelpe baculovirus samt fremgangsmate for fremstilling av rekombinante virus. NO323937B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9614278A FR2756297B1 (fr)	1996-11-22	1996-11-22	Procede de production de virus recombinants
PCT/FR1997/002073 WO1998022607A1 (fr)	1996-11-22	1997-11-18	Procede de production de virus recombinants

Publications (3)

Publication Number	Publication Date
NO992464D0 NO992464D0 (no)	1999-05-21
NO992464L true NO992464L (no)	1999-06-23
NO323937B1 NO323937B1 (no)	2007-07-23

Family

ID=9497899

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO19992464A NO323937B1 (no)	1996-11-22	1999-05-21	Rekombinante hjelpe baculovirus samt fremgangsmate for fremstilling av rekombinante virus.
NO2013009C NO2013009I1 (no)	1996-11-22	2013-04-15	Alipogen tiparvovec

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO2013009C NO2013009I1 (no)	1996-11-22	2013-04-15	Alipogen tiparvovec

Country Status (18)

Country	Link
US (2)	US6387670B1 (no)
EP (1)	EP0946741B1 (no)
JP (1)	JP4686670B2 (no)
KR (1)	KR100719645B1 (no)
AT (1)	ATE317908T1 (no)
AU (1)	AU731106B2 (no)
BR (1)	BR9713388B1 (no)
CA (1)	CA2271438C (no)
CZ (1)	CZ293947B6 (no)
DE (1)	DE69735274T2 (no)
ES (1)	ES2260803T3 (no)
FR (1)	FR2756297B1 (no)
HU (1)	HU224713B1 (no)
IL (1)	IL129686A (no)
NO (2)	NO323937B1 (no)
SK (1)	SK286900B6 (no)
WO (1)	WO1998022607A1 (no)
ZA (1)	ZA9710516B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003501042A (ja) *	1999-05-27	2003-01-14	ジェノボ，インコーポレイテッド	非哺乳動物ウイルス由来のキャリアベクターを使用する、組換えウイルスの産生のための組成物および方法
US6793926B1 (en) *	1999-05-27	2004-09-21	Genovo, Inc.	Methods for production of a recombinant adeno-associated virus
WO2000073424A1 (en) *	1999-05-28	2000-12-07	Mount Sinai School Of Medicine	A novel baculovirus/adenovirus hybrid vector for the rescue, production and titration of high-capacity adenovirus amplicon vectors
GB9919409D0 (en) *	1999-08-18	1999-10-20	Univ Oxford Brookes	Baculovirus expression system
WO2004020605A2 (en) *	2002-08-29	2004-03-11	The Board Of Trustees Of The Leland Stanford Junior University	Circular nucleic acid vectors, and methods for making and using the same
GB0702695D0 (en) *	2007-02-12	2007-03-21	Ark Therapeutics Ltd	Production of vectors
GB0702694D0 (en) *	2007-02-12	2007-03-21	Ark Therapeutics Ltd	Vectors
EP2019143A1 (en)	2007-07-23	2009-01-28	Genethon	CNS gene delivery using peripheral administration of AAV vectors
EP2058401A1 (en)	2007-10-05	2009-05-13	Genethon	Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
EP2249950B1 (en) *	2008-03-05	2014-10-15	Council of Scientific & Industrial Research	A polymeric hybrid membrane
EP2287323A1 (en)	2009-07-31	2011-02-23	Association Institut de Myologie	Widespread gene delivery to the retina using systemic administration of AAV vectors
EP2292781A1 (en)	2009-08-17	2011-03-09	Genethon	Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
CN102884196B (zh) *	2010-04-01	2015-05-06	肖卫东	重组病毒载体的结构及其制备
BR112012026095A2 (pt)	2010-04-14	2015-09-15	Emd Millipore Corp	métodos de produção de estoques de vírus de alta pureza e altos títulos e métodos de uso dos mesmos.
WO2013170078A1 (en)	2012-05-09	2013-11-14	Oregon Health & Science University	Adeno associated virus plasmids and vectors
TWI698240B (zh)	2012-05-15	2020-07-11	澳大利亞商艾佛蘭屈澳洲私營有限公司	使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
US20150182637A1 (en)	2012-06-21	2015-07-02	Association Institut De Myologie	Widespread gene delivery of gene therapy vectors
WO2015031686A1 (en) *	2013-08-30	2015-03-05	Amgen Inc.	High titer recombinant aav vector production in adherent and suspension cells
EP3800191B1 (en)	2014-03-17	2025-08-20	Adverum Biotechnologies, Inc.	Compositions and methods for enhanced gene expression in cone cells
US11021519B2 (en)	2015-03-02	2021-06-01	Adverum Biotechnologies, Inc.	Compositions and methods for intravitreal delivery of polynucleotides to retinal cones
GB2545763A (en)	2015-12-23	2017-06-28	Adverum Biotechnologies Inc	Mutant viral capsid libraries and related systems and methods
US10538571B2 (en)	2017-11-27	2020-01-21	Coda Biotherapeutics, Inc.	Compositions and methods for neurological diseases
US20190256867A1 (en)	2018-02-01	2019-08-22	Homology Medicines, Inc.	Adeno-associated virus compositions for restoring pah gene function and methods of use thereof
US10610606B2 (en)	2018-02-01	2020-04-07	Homology Medicines, Inc.	Adeno-associated virus compositions for PAH gene transfer and methods of use thereof
JP7244547B2 (ja)	2018-02-19	2023-03-22	ホモロジー・メディシンズ・インコーポレイテッド	Ｆ８遺伝子機能を回復させるためのアデノ随伴ウイルス組成物及びその使用の方法
US12215338B2 (en)	2018-05-08	2025-02-04	Neuracle Science Co., Ltd.	Adeno-associated virus (AAV) delivery of anti-FAM19A5 antibodies
WO2020160508A1 (en)	2019-01-31	2020-08-06	Oregon Health & Science University	Methods for using transcription-dependent directed evolution of aav capsids
AU2020334147A1 (en)	2019-08-21	2022-03-31	Trames Bio, Inc.	Compositions and methods for neurological diseases
TW202140791A (zh)	2020-01-13	2021-11-01	美商霍蒙拉奇醫藥公司	治療苯酮尿症之方法
TW202208632A (zh)	2020-05-27	2022-03-01	美商同源醫藥公司	用於恢復ｐａｈ基因功能的腺相關病毒組成物及其使用方法
GB202013940D0 (en)	2020-09-04	2020-10-21	Synpromics Ltd	Regulatory nucleic acid sequences
CA3195177A1 (en)	2020-10-07	2022-04-14	Asklepios Biopharmaceutical, Inc.	Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy disorders including limb girdle 2i (lgmd2i)
US20250296996A1 (en)	2022-04-29	2025-09-25	Broadwing Bio, Inc.	Angiopoietin-related protein 7-specific antibodies and uses thereof
EP4514844A1 (en)	2022-04-29	2025-03-05	Broadwing Bio LLC	Complement factor h related 4-specific antibodies and uses thereof
KR20250018169A (ko)	2022-04-29	2025-02-04	브로드윙 바이오 엘엘씨	이중특이적 항체 및 안구 질환의 치료 방법
WO2024227154A1 (en)	2023-04-28	2024-10-31	Broadwing Bio Llc	Complement component 3 (c3)-specific antibodies and uses thereof
WO2025040613A1 (en) *	2023-08-21	2025-02-27	Vector Biopharma Ag	Cell line for production of helper-dependent adenoviruses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2755817B2 (ja) *	1988-11-14	1998-05-25	アメリカ合衆国	パルボウイルスキャプシド
US5559099A (en) *	1994-09-08	1996-09-24	Genvec, Inc.	Penton base protein and methods of using same
JPH10506530A (ja) *	1994-09-23	1998-06-30	ザジェネラルホスピタルコーポレーション	哺乳類細胞において外来遺伝子を発現する非哺乳類ｄｎａウイルスの使用

1996
- 1996-11-22 FR FR9614278A patent/FR2756297B1/fr not_active Expired - Lifetime
1997
- 1997-11-18 ES ES97947083T patent/ES2260803T3/es not_active Expired - Lifetime
- 1997-11-18 BR BRPI9713388-4A patent/BR9713388B1/pt not_active IP Right Cessation
- 1997-11-18 JP JP52328298A patent/JP4686670B2/ja not_active Expired - Lifetime
- 1997-11-18 DE DE69735274T patent/DE69735274T2/de not_active Expired - Lifetime
- 1997-11-18 HU HU0001762A patent/HU224713B1/hu active Protection Beyond IP Right Term
- 1997-11-18 IL IL12968697A patent/IL129686A/xx not_active IP Right Cessation
- 1997-11-18 CZ CZ19991822A patent/CZ293947B6/cs not_active IP Right Cessation
- 1997-11-18 US US09/308,398 patent/US6387670B1/en not_active Expired - Lifetime
- 1997-11-18 SK SK666-99A patent/SK286900B6/sk not_active IP Right Cessation
- 1997-11-18 KR KR1019997004531A patent/KR100719645B1/ko not_active Expired - Lifetime
- 1997-11-18 AU AU52261/98A patent/AU731106B2/en not_active Expired
- 1997-11-18 EP EP97947083A patent/EP0946741B1/fr not_active Expired - Lifetime
- 1997-11-18 AT AT97947083T patent/ATE317908T1/de not_active IP Right Cessation
- 1997-11-18 WO PCT/FR1997/002073 patent/WO1998022607A1/fr not_active Ceased
- 1997-11-18 CA CA2271438A patent/CA2271438C/fr not_active Expired - Lifetime
- 1997-11-21 ZA ZA9710516A patent/ZA9710516B/xx unknown
1999
- 1999-05-21 NO NO19992464A patent/NO323937B1/no not_active IP Right Cessation
2002
- 2002-05-09 US US10/141,491 patent/US20030022356A1/en not_active Abandoned
2013
- 2013-04-15 NO NO2013009C patent/NO2013009I1/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO323937B1 (no)	2007-07-23
FR2756297A1 (fr)	1998-05-29
DE69735274D1 (de)	2006-04-20
BR9713388A (pt)	2000-03-21
HU224713B1 (en)	2006-01-30
NO992464D0 (no)	1999-05-21
ZA9710516B (en)	1998-06-10
CA2271438A1 (fr)	1998-05-28
DE69735274T2 (de)	2006-10-12
ES2260803T3 (es)	2006-11-01
CZ182299A3 (cs)	1999-08-11
AU5226198A (en)	1998-06-10
CA2271438C (fr)	2010-10-26
ATE317908T1 (de)	2006-03-15
EP0946741B1 (fr)	2006-02-15
FR2756297B1 (fr)	1999-01-08
AU731106B2 (en)	2001-03-22
SK286900B6 (sk)	2009-07-06
NO2013009I1 (no)	2013-04-29
KR20000057202A (ko)	2000-09-15
EP0946741A1 (fr)	1999-10-06
WO1998022607A1 (fr)	1998-05-28
US20030022356A1 (en)	2003-01-30
BR9713388B1 (pt)	2009-01-13
KR100719645B1 (ko)	2007-05-17
CZ293947B6 (cs)	2004-08-18
IL129686A0 (en)	2000-02-29
HUP0001762A2 (hu)	2000-09-28
SK66699A3 (en)	2000-02-14
IL129686A (en)	2005-12-18
JP4686670B2 (ja)	2011-05-25
JP2001503993A (ja)	2001-03-27
US6387670B1 (en)	2002-05-14
HUP0001762A3 (en)	2002-01-28

Legal Events

Date	Code	Title	Description
2010-12-20	CREP	Change of representative	Representative=s name: EHRNER & DELMAR PATENTBYRA AB, BOX
2011-05-16	CREP	Change of representative	Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA
2013-04-22	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: SANOFI, FR
2013-04-29	SPCF	Filing of supplementary protection certificate	Free format text: PRODUCT NAME: GLYBERA; REG. NO/DATE: EU/1/12/791/001 20121206 Spc suppl protection certif: 2013009 Filing date: 20130415
2017-12-11	MK1K	Patent expired

Publication	Publication Date	Title
NO992464D0 (no)	1999-05-21	FremgangsmÕte for fremstilling av rekombinante viruser
NO993247D0 (no)	1999-06-29	FremgangsmÕte for fremstilling av tolterodin
BG102577A (bg)	1999-04-30	Нови 5-амино-3-циано-4-етилсулфинил-1-фенилпиразоли, метод за получаване и използването им като пестициди
DE69534778D1 (en)	2006-04-20	Cathepsin-02-protease
ID17055A (id)	1997-12-04	Suatu bahan optoelektronik, alat penerapannya dan metode pembuatan bahan optoelektronik tersebut
PT757717E (pt)	2006-09-29	Vacinas de papilomavirus
ATE280178T1 (de)	2004-11-15	Langwellig fluorezierende proteine
ID18046A (id)	1998-02-19	Senyawa siklik campuran, pembuatan dan penngunaannya.
EA200000196A1 (ru)	2000-10-30	Универсальная плазма крови
WO1999067393A3 (de)	2000-03-30	Strukturprotein von aav, seine herstellung und verwendung
EE03693B1 (et)	2002-04-15	Isoleeritud dimeerne fibroblastide aktivatsioonivalk alfa ja selle kasutusalad
DK1342718T3 (da)	2005-09-26	N-alkylerede ureider
DK0638068T3 (da)	1999-11-22	Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
ID24633A (id)	2000-07-27	Turunan tetrahidropirimidinon 3-tersubstitusi, pembuatan dan penggunaannya
ATE286908T1 (de)	2005-01-15	Gewebespezifische expression des retinoblastoma- proteins
ES2179908T3 (es)	2003-02-01	Acidos sacarosamonocarboxilicos acilados.
WO1997035015A3 (de)	1997-12-18	Tyrosin-phosphatase-verwandtes protein
DE59611293D1 (de)	2005-12-15	Protein mit dnase-aktivität
DK1032580T3 (da)	2004-08-02	Fremgangsmåde til N-desmethylering af erythromyciner og derivater deraf
SE0102060D0 (sv)	2001-06-11	Electric sauna stove
TR200103662T2 (tr)	2002-05-21	Yeni kalpainler ve bunların kullanılması
ATE209910T1 (de)	2001-12-15	Verwendung von 6,7-substituierter 2- aminotetraline zur behandlung von zytokin- vermittleten entzündungszuständen
WO1997012969A3 (de)	1997-07-17	Fmr1-verwandtes protein
SE9604093D0 (sv)	1996-11-08	Filter
ITLE940008A1 (it)	1996-04-26	Polfos